Legal Memo: Overview of Recent Warning Letters
AAHP Counsel, Al Lorman, has prepared a memo with an overview of recent warning letters, especially highlighting issues raised in the group of warning letters to manufacturers of homeopathic products…
Read MoreTwo Additional Topics Expand Continuing Education Program for Pharmacists on Homeopathic Drugs
Topics on colds and flu and calendula were recently launched through Pharmacy Times Continuing Education (PTCE), division of Pharmacy Times®. Pharmacists and pharmacy technicians can receive continuing education credits after…
Read MoreHow to Stop Bad Inspections: It Starts with Staff
By Mark Land, AAHP President At AAHP, we firmly believe that compliance with quality and safety regulations is crucial for all homeopathic manufacturers. To educate our community, we’ve published…
Read MoreAnatomy of a Compliant Drug Facts Panel
In my May 2020 article entitled The Anatomy of a Compliant Homeopathic Label, I covered The importance of considering the intended use statements that will be placed on the label
Read MoreThe Anatomy of a Compliant Homeopathic Label
By Eric L. Foxman, R.Ph., AAHP Secretary | Before examining the details of a compliant homeopathic drug product label, it is important to consider labeling in relation to the FDA Draft Enforcement Guidance.
Read MoreIs the Homeopathic Industry Underinvesting in Quality Systems?
By Mark Land, AAHP President | I’ve been pondering this question for some time, ever since preparing for my presentation on FDA enforcement trends during AAHP’s Quality and Safety Summit last June in Baltimore.
Read MoreRetail in the COVID-19 Pandemic
The COVID-19 pandemic will likely be very painful formany legacy retailers such asKohl’s, J.C. Penney, and Macy’s, who are among the thousands of retailers forced to temporarily closetheirdoorsand could see an annual earnings drop of 50percent.To further complicatethis already precarious situation,other big-box retailers such as Target, Walmart Whole FoodsMarket/Amazon and Costco continue to thrive and take market share from these players even duringthisCOVID-19isolation period.
Read MoreCOVID-19 CARES Act Aids Availability of OTC Products
On March 27, President Trump signed into law the Coronavirus Aid Relief and Economic Security (CARES) Act (HR 748). This landmark legislation provides financial relief for workers, small businesses, and healthcare professionals affected by the coronavirus…
Read MoreFDA’s Compendial Operations and Standards Branch (COSB)
FDA’s Compendial Operations and Standards Branch (COSB) a branch within FDA’s Office of Pharmaceutical Quality (OPQ) is responsible for the management of agency staff selection and the maintenance of participation in standards development activities…
Read MoreHomeopathy Mentioned Twice in FDA 2021 Budget Is Telling of Issues to Come
By Mark Land, AAHP President | In February, the White House released the President’s Fiscal Year 2021 Budget. Correspondingly, each agency publishes a detailed budget justification…
Read More